
1. Science. 2011 Aug 5;333(6043):705-6. doi: 10.1126/science.1210875.

Microbiology. Exploiting malaria drug resistance to our advantage.

Cammack N(1).

Author information: 
(1)GlaxoSmithKline, Madrid, 28760 Spain. nicholas.c.cammack@gsk.com

Comment on
    Science. 2011 Aug 5;333(6043):724-9.

DOI: 10.1126/science.1210875 
PMID: 21817037  [Indexed for MEDLINE]

